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celi lung cancer. Assessed was the impact of
either treatment on the degree and duration of
relief of tumor-related symptoms and on
patient's performance status. Secondary
endpoints included treatment side-effects,
objective response and overall survival. One
hundred patients were randomly assigned to the
dose of 20 Gy/5x15 days (Arm A) or 16 Gy/2x18
days (Arm B). There were 90 men and 10
women aged between 47 and 79 (mean 66).
Eighty four patients had locally advanced tumor
and 16 patients had metastatic disease.
Squamous celi carcinoma was diagnosed in 65
patients, adenocarcinoma - in 9 patients, large
celi carcinoma - in 1 patient and unspecified
non-smali celi carcinoma - in 25 patients. Fifty
five patients were assigned to Arm A and 45 - to
Arm B. Ninety eight patients received assigned
treatment whereas twa patients died before the
end of treatment. The final results of the study
will be presented at the conference.
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A prospective, randomized multicenter study
was conducted to assess the value of amifostine
(Ethyol®) as a radioprotectant in head and neck
cancer radiotherapy. The aim of the study was
to evaluate the impact of the addition of daily
amifostine (150 mg/m2) on the degree of early
(mucositis, dysphagia, xerostomia) and late
(mucosal, cutaneous, salivary gland, mandible
and spinaj cord) radiation reactions. Assessed
were aiso patients' quality of life, local control
and overall survival. Sixty two patients fram five
Polish institutions were randomly assigned to
radiotherapy alone (Arm A - 28 patients) or
radiotherapy + amifostine (Arm B - 34 patients).
There were 43 men and 19 women. Primary
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tumor was located in the aral cavity (27
patients), oropharynx (25 patients), nasopharynx
(2 patients) and larynxlhypopharynx (8 patients).
In 43 patients radiotherapy was used as the sole
modality of tretatment and 19 patients were
irradiated postoperatively. The side effects of
amifostine were manageable. In 6 patients
amifostine intusion had to be temporarily
stopped due to hypotension and in 5 patients its
administration was permanently terminated due
to hypotension, nausea and vomiting,
septicemia or tever and visual disturbances. The
early results ot the study, tocusing on early
radiation reactions, will be presented at the
conterence.
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THE OWN EXPERIENCE IN
MONITORING THE LATE RADlATlON
REACTION OF CRITICUAL TISSUES
IN HEAD AND NECK REGION
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W.Przeorekl, B.Pilecki1 M.Sygułal,
Z. Kołosza 3
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Purpose: The estimation of scoring system
SOMA-LENT in classitication the late radiation
toxicity in patients with squamous celi cancer
irradiated in H&N region.
Material and methods:_The material includes
97 patients with orał cavity, pharyngeal and
supraglottic cancer T2•4No-1 irradited by
conventionał method (18 patients), continous
accelerated irradiation CAIR (42 patients) and
concomitant boost CB (37 patients). Total dose
was in range 66-74 Gy. The late radiation
taxicity was evaluated by SOMA-LENT system
for pharyngeal and aral cavity mucosal
membrane, skin, larynx, salivary glands, spinaj
cord. The estimation was done every
6 months after completing ot radiotherapy. In
statistical analysis the values were normalisated
to maximai intensity ot all symptoms in the
scale.
Results: The intensity ot late radiation toxicity
for mucosal membrane was increasing between
1i h-18 th month after radiotherapy and next
decreased from 24 after irradiation. For skin the
intensity of late radiation reaction increased to
24 months after treatment. For larynx we noticed
two peaks ot late radiation toxicity: between
18th_24th month and about 54 month after
irradiation. The intensity ot late radiation effect
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